| 000 | 01510 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515043002.0 | ||
| 264 | 0 | _c20070124 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0364-3190 | ||
| 024 | 7 |
_a10.1007/s11064-006-9166-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Zhihao | |
| 245 | 0 | 0 |
_aNeuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. _h[electronic resource] |
| 260 |
_bNeurochemical research _cOct 2006 |
||
| 300 |
_a1263-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmyotrophic Lateral Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCatechin _xanalogs & derivatives |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aMicroglia _xpathology |
| 650 | 0 | 4 |
_aMotor Neurons _xpathology |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 700 | 1 | _aChen, Sheng | |
| 700 | 1 | _aLi, Xuping | |
| 700 | 1 | _aLuo, Guangrui | |
| 700 | 1 | _aLi, Liang | |
| 700 | 1 | _aLe, Weidong | |
| 773 | 0 |
_tNeurochemical research _gvol. 31 _gno. 10 _gp. 1263-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11064-006-9166-z _zAvailable from publisher's website |
| 999 |
_c16598962 _d16598962 |
||